Viewing StudyNCT00480584



Ignite Creation Date: 2024-05-05 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00480584
Status: COMPLETED
Last Update Posted: 2012-11-08
First Post: 2007-05-29

Brief Title: A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Sponsor: H Lee Moffitt Cancer Center and Research Institute
Organization: H Lee Moffitt Cancer Center and Research Institute

Organization Data

Organization: H Lee Moffitt Cancer Center and Research Institute
Class: OTHER
Study ID: MCC-14624
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: H Lee Moffitt Cancer Center and Research Institute
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Genentech Inc INDUSTRY